Vertex Pharmaceuticals Add us as a preferred source on Google
🔄 Data last refreshed 2 months ago
🤝
Make a deal with Vertex Pharmaceuticals
👋 Unclaimed listing — auto-generated from public data; rates are estimates, not set by the creator. 🔒 Paid proposals held safely in escrow — released only when the work's approved.
This is an unclaimed, auto-generated listing. It was built only from Vertex Pharmaceuticals’s publicly available X information. Vertex Pharmaceuticals has not claimed, verified, or endorsed it, and is not affiliated with, sponsored by, or a partner of SocialDB — no partnership or endorsement is implied, and any prices shown are estimates, not set by the creator.
Followers
70K
Posts
3.6K
Following
83
Account age
17 yrs
💰 Suggested sponsorship rate
$392 – $637 / sponsored post
Estimated from audience size & typical reach — every deal is negotiable and held in SocialDB escrow.
🎁 Free analysisfor Vertex Pharmaceuticals
Known for
2.4K views
We are pleased to share new data from multiple studies of our gene-edited therapy for sickle cell disease and transfusion-dependent beta thalassemia at the 67th ASH Annual Meeting this weekend. Learn more: https://t.co/LbVnijbX6R #ASH25
2.2K views
We have entered a new reimbursement agreement for our latest #CysticFibrosis (CF) therapy in #Bulgaria. This new agreement has enabled broad access for eligible people living with CF ages 6 years and older since Jan 5, 2026.
1.9K views
Major update for the treatment of cystic fibrosis (CF) in the U.S.: The FDA has approved the label extension for our triple combination therapies, expanding availability of these medicines to ~95% of all people with CF in the U.S.
Learn more: https://t.co/3GMdzqJbQ4
1.9K views
Today we announced an agreement to acquire @Crinetics. This deal adds to our portfolio of transformative medicines & leverages our strengths in R&D & commercialization to bring more potentially best-in-class medicines to patients with serious diseases. https://t.co/itLnyPRjka
📊 Post performance
Recent posts · views
Feb 20latest
1.6K
Avg views / post
1.4K–1.7K
Typical post (views)
2.3%
Reach vs followers
92/100
Very consistent reach
Nov 2008
On X since
Half of recent posts land between 1.4K and 1.7K views (median 1.6K) — a dependable floor a sponsored post can count on.
🔥 Top post: We are pleased to share new data from multiple studies of our ge · 2.4K views
📊 Activity & format
Posting cadence
0.43 / week
A lower-frequency account — each post lands with more weight.
Content mix
Mostly images
Recent: 2 video · 15 image · 1 text.
Follower / following
843×
Follows 83 back. A strong ratio — an audience that follows them, not a follow-for-follow network.
Recent posts
View on X ↗
🔥 Top post
We are pleased to share new data from multiple studies of our gene-edited therapy for sickle cell disease and transfusion-dependent beta thalassemia at the 67th ASH Annual Meeting this weekend. Learn more: https://t.co/LbVnijbX6R #ASH25
We have entered a new reimbursement agreement for our latest #CysticFibrosis (CF) therapy in #Estonia. This new agreement will enable broad access for eligible people living with CF ages 6 years and older from October 1, 2026.
▶
We announced positive Phase 2b AMPLIFIED results and completion of enrollment in the Phase 2/3 AMPLITUDE trial for people living with APOL1-mediated kidney disease.
Learn more: https://t.co/UsbRNMSkhB
We have entered a new reimbursement agreement for our latest #CysticFibrosis (CF) therapy in #Latvia. This new agreement has enabled broad access for eligible people living with CF ages 6 years and older since August 17, 2026.
Extended reimbursement agreement with health authorities in #Uruguay: Since July 2026 eligible children living with #CysticFibrosis ages 2 years and older have broad access to one of our medicines.
Today we announced an agreement to acquire @Crinetics. This deal adds to our portfolio of transformative medicines & leverages our strengths in R&D & commercialization to bring more potentially best-in-class medicines to patien…
A landmark update for children living with #SickleCellDisease or #TransfusionDependentBetaThalassemia: The @US_FDA has approved a label extension for our #CRISPR-based therapy.
Learn more: https://t.co/ivINa0xQwE
We presented data on our gene-edited therapy for people with sickle cell disease or transfusion-dependent beta thalassemia at the European Hematology Association (EHA) Congress and announced regulatory submissions for potential future use …
Extended reimbursement agreement with National Health Insurance Fund in #NorthMacedonia: Since May 20, 2026, eligible people living with #CysticFibrosis ages 2 years and older have broad access to one of our medicines.
We are proud to announce that the U.S. FDA has accepted our Biologics License Application (BLA) for our investigational therapy for #IgANephropathy. Learn more: https://t.co/1EYB9Ukl1W
First reimbursement agreement in #Chile: Eligible people living with #CysticFibrosis now have reimbursed access to one of our #CysticFibrosis therapies.
Major update for the treatment of cystic fibrosis (CF) in the U.S.: The FDA has approved the label extension for our triple combination therapies, expanding availability of these medicines to ~95% of all people with CF in the U.S.
Learn mo…
We’re excited to share positive topline results from the interim analysis of the RAINIER Phase 3 study of our investigational therapy for #IgANephropathy. Learn more: https://t.co/1bgWKtIJiq
💡 Facts
🗓️Joined X in 2008 — 17 years ago.
👁️Averages 1.6K views per post.
📤Posts about 0.4× per week.
💬0.02% engagement rate.
🏅Earned the 10K Followers for passing 10K followers.
🕵️ Fake follower check
Estimated37/100
Low
Credibility score
66%
Mixed
Real audience
Medium
Fake-follower risk
High
Data confidence
- Est. 66% real, active audience · Medium fake-follower risk.
- Low engagement (~2.3% of followers engage each post) — a sign of an inflated or inactive audience.
- Organic base — far more followers than accounts it follows.
- Established account (17+ years old).
- 0.02% engagement — below the ~8.8% typical for this size.
Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.
About
The official channel for Vertex Pharmaceuticals. http://bit.ly/3Bvj6WE
📸 Gallery
🔀 Audience overlap
EstimatedEstimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.
Quasar Markets
16%
Ethiopian News Agency
14%
Cline
13%
Walker Books
12%
Allan Dos Santos
11%
पुणे ग्रामीण पोलीस - Pune Rural Police
10%
More like this
Find more →
X
＋
Ethiopian News Agency
@ethiopiannewsa
371.2K
Followers
X
＋
पुणे ग्रामीण पोलीस - Pune Rural Police
@puneruralpolice
87.5K
Followers
X
＋
Cline ✓
@cline
72.2K
Followers
X
＋
Allan Dos Santos ✓
@allanldsantos
389.8K
Followers
X
＋
Quasar Markets
@quasarmarkets
160.3K
Followers
X
＋
Walker Books
@walkerbooksuk
67.5K
Followers
Frequently asked questions
How much does Vertex Pharmaceuticals charge for a sponsorship?
Vertex Pharmaceuticals hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.
How do I contact Vertex Pharmaceuticals for a brand deal or collaboration?
Send a paid deal or collab request right here on SocialDB — we notify Vertex Pharmaceuticals, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.
How many followers does Vertex Pharmaceuticals have?
Vertex Pharmaceuticals has 69,984 followers on X.
✉ Message Vertex Pharmaceuticals
Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.
- ✓ Message any influencer from their listing
- ✓ The influencer gets notified by email
- ✓ Manage every conversation in one inbox
Already Pro? Log in.
🎤 Event / appearance with Vertex Pharmaceuticals
Booking an event / appearance is a Pro feature. Upgrade to book Vertex Pharmaceuticals for an in-person or virtual appearance — payment held safely in escrow until the event is done.
- ✓ Book them for events, livestreams, panels & more
- ✓ Vertex Pharmaceuticals gets notified by email
- ✓ Fee held in escrow, released after the appearance
Already Pro? Log in.
🚧
Vertex Pharmaceuticals isn't on SocialDB yet
Vertex Pharmaceuticals hasn't claimed this listing yet, so they can't accept sponsorships, collabs or other deals here. The prices shown are estimates.
🚀
You're out of free requests this month
Free accounts get 5 per month. Go Pro for unlimited sponsor pitches, collab requests & sponsorship deals — plus featured placement, the Verified badge, free withdrawals and more.
Upgrade to Pro — $9.95/mo →Your free limit resets on the 1st of next month.